Stay updated on ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial

Sign up to get notified when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the webpage content.
    Difference
    0.3%
    Check dated 2024-06-13T21:14:46.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in medical or healthcare-related publications or documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:23:17.000Z thumbnail image
  7. Check
    22 days ago
    Change Detected
    Summary
    The value 03 on the webpage has recently changed to 24, indicating a significant update in the study record details related to a clinical trial for patients with relapsed or refractory Acute Myeloid Leukemia (AML) with FLT3 mutation. This change may be crucial for individuals monitoring medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-05-25T03:45:21.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of certain medical or healthcare-related publications or documentation. This change may reflect new information or additional entries in the relevant category.
    Difference
    0.3%
    Check dated 2024-05-22T20:28:43.000Z thumbnail image
  9. Check
    43 days ago
    Change Detected
    Summary
    The value 04 04 on the webpage has recently changed to 05 03, indicating a modification in the study record posted on 2024-05-03 related to a Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FLT3 Mutation.
    Difference
    0.6%
    Check dated 2024-05-04T09:41:46.000Z thumbnail image
  10. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:33:20.000Z thumbnail image

Stay in the know with updates to ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.